A mixture of hydrogenated ergot alkaloids consisting of the methanesulfonic acid salts of dihydroergocornine (R = CHMe2), dihydroergocristine (R = CH2Ph), and alpha- and beta-dihydroergocryptine (R = CH2CHMe2 and CH(Me)Et, respectively). It is used for the symptomatic treatment of mild to moderate dementia in the elderly, although its value is not established.
Term information
- DrugBank:DB01049
- CAS:8067-24-1
- Beilstein:8896265
- KEGG:D02268
- KEGG:C14055
3_STAR
ergoloid methanesulfonate
Dihydroergotoxine mesylate
codergocrine methanesulfonate
hydrogenated ergot alkaloids
dihydroergotoxine monomethanesulfonate
ergoloid mesylates
codergocrine mesilate
co-dergocrine mesylate
Ergoloid mesylates
Dihydroergotoxine mesilate
ergoloid methanesulfonates
dihydrogenated ergot alkaloids
co-dergocrine methanesulfonate
dihydroergotoxine methanesulfonate
dihydroergotoxine methanesulfonates
codergocrine mesylate
co-dergocrine mesilate
C1=CC=C2NC=C3C[C@@]4([C@](C[C@H](CN4C)C(N[C@]5(C(N6[C@@](O5)([C@]7(N(C([C@@H]6*)=O)CCC7)[H])O)=O)C(C)C)=O)(C1=C32)[H])[H].OS(C)(=O)=O